The board of directors of InnoCare Pharma Limited announced that Ms. Yeung Ching Man has tendered her resignation as the company secretary of the Company and has ceased to act as (i) an authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange"); and (ii) an authorized representative of the Company under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) for the acceptance of service of process and notices in Hong Kong (the "Process Agent") with effect from 9 February 2021. The Board also announced that Mr. Wong Keith Shing Cheung ("Mr. Wong") has been appointed as the Company Secretary, Authorised Representative and Process Agent in replacement of Ms. Yeung with effect from 9 February 2021. Mr. Wong is a senior manager of SWCS Corporate Services Group (Hong Kong) Limited. Mr. Wong has over ten years of experience in the accounting, finance and corporate services field. He obtained a bachelor's degree in finance, accounting and management from University of Nottingham, and is a member of the Hong Kong Institute of Certified Public Accountants.